SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
(Check One): [ ] Form 10-K [ ] Form 11-K [ ] Form 20-F
[X] Form 10-Q [ ] Form N-SAR
For Period Ended: June 30, 1999
[ ] Transition Report on Form 10-K [ ] Transition Report on Form 10-Q
[ ] Transition Report on For 2-F [ ] Transition Report on Form N-SAR
[ ] Transition Report on Form 11-K
For the Transition Period Ended:
Read attached instruction sheet before preparing form.
Please print or type.
Nothing in this form shall be construed to imply that the Commission
has verified any information contained herein.
If the notification relates to a portion of the filing checked above,
identify the item(s) to which the notification relates:
PART I
REGISTRANT INFORMATION
Full name of registrant: Medical Device Alliance Inc.
Former name if applicable: N/A
Address of principal executive office (Street and number)
3800 Howard Hughes Parkway, Suite 1800
City, state and zip code Las Vegas, Nevada 89109
PART II
RULE 12b-25 (b) AND (C)
If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25 (b), the
following should be completed. (Check box if appropriate.)
[X] (a) The reasons described in reasonable detail in Part III of
this form could not be eliminated without unreasonable effort
or expense;
[ ] (b) The subject annual report, semi-annual report, transition
report on Form 10-K, 20-F, 11-K or Form N-SAR, or portion
thereof will be filed on or before the 15th calendar day following
the prescribed due date; or the subject quarterly report or transition
report on Form 10-Q, or portion thereof will be filed on or before the
fifth calendar day following the prescribed due date; and
[ ] (c) The accountant's statement or other exhibit required by
Rule 12b-25 (c) has been attached if applicable.
PART III
NARRATIVE
State below in reasonable detail the reasons why Form 10-K, 11-K, 20-F, 10-Q,
N-SAR or the transition report portion thereof could not be filed within the
prescribed time period. (Attach extra sheets if needed.)
The Company has been involved in legal actions, the most significant being a
patent infringement dispute in which the Company prevailed, and a civil
action which resulted in the appointment of a Receiver, George C. Swarts,
with full power for the Company and all of its subsidiaries and affiliates
pursuant to a hearing in late June 1999. These and other significant factors
have been disclosed in previous filings with the Securities and Exchange
Commission (including on Forms 12b-25 filed on March 26, 1999 and May 13,
1999) and have caused, among other things, a significant burden on management
and reductions in the employee base, including the loss of two controllers since
December 1998 at LySonix Incorporated, the most significant operating
subsidiary of the Company. These factors have delayed the examination of the
Company's 1998 consolidated financial statements by its independent
accountants and made it to where the filing of the Company's second quarter
report on Form 10-QSB by the prescribed due date cannot be accomplished
without the incurrence of unreasonable effort and expense.
PART IV
OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to
this notification
George C. Swarts (702) 791-2910
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or 15(d)
of the Securities Exchange Act of 1934 or Section 30 of the
Investment Company Act of 1940 during the preceding 12 months or
for such shorter period that the registrant was required to file
such report(s) been filed?
If the answer is no, identify report(s).
[ ] Yes [X] No
Form 10-KSB for the year ended December 31, 1998 and Form 10- QSB
for the quarter ended March 31, 1999 (see Part III).
(3) Is it anticipated that any significant change in results of
operations from the corresponding period for the last fiscal year
will be reflected by the earnings statements to be included in
the subject report or portion thereof?
[ ] Yes [X] No
If so: attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a
reasonable estimate of the results cannot be made.
MEDICAL DEVICE ALLIANCE INC.
(Name of Registrant as Specified in Charter)
Has caused this notification to be signed on its behalf by
the undersigned thereunto duly authorized.
Date July 29, 1999 By /s/ Charles E. Barrantes
